A systematic review with meta‐analysis: Efficacy and safety of potassium‐competitive acid blocker compared with proton pump inhibitor in the maintenance of healed …
DM Simadibrata, E Lesmana, MIA Pratama… - JGH …, 2024 - Wiley Online Library
Introduction Proton pump inhibitor (PPI) is the mainstay therapy for the maintenance of
healed erosive esophagitis (EE). It is unknown whether potassium‐competitive acid blockers …
healed erosive esophagitis (EE). It is unknown whether potassium‐competitive acid blockers …
Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?
Introduction Proton pump inhibitor (PPI) has revolutionized the treatment of erosive
esophagitis (EE) in the past few decades. However, roughly 30–40% of the patients …
esophagitis (EE) in the past few decades. However, roughly 30–40% of the patients …
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi‐Center, Randomized, Double‐Blind, Active‐Comparator …
CM Shin, SC Choi, JW Cho, SY Kim… - …, 2025 - Wiley Online Library
Background The aims of this study were to confirm the non‐inferiority of tegoprazan to
lansoprazole up to week 4 in patients with erosive esophagitis (EE) and to evaluate its …
lansoprazole up to week 4 in patients with erosive esophagitis (EE) and to evaluate its …
Potassium-competitive acid blockers and acid-related disorders
KZ Huang, HC Weber - Current Opinion in Endocrinology …, 2024 - journals.lww.com
Potassium-competitive acid blockers and acid-related disorde... : Current Opinion in
Endocrinology, Diabetes and Obesity Potassium-competitive acid blockers and acid-related …
Endocrinology, Diabetes and Obesity Potassium-competitive acid blockers and acid-related …